Prevention

Ervebo has been approved for the prevention of Ebola virus disease, caused by Zaire ebolavirus in individuals 18 years of age and older.

Investigators assessing how frequently antibiotics are prescribed without a documented indication discovered that 18% of antibiotic prescriptions had no documented indication in a nationally representative sample of ambulatory clinic encounters.

Incorporating a signaling protein known as B cell activating factor into the rabies vaccine improved speed and strength of the antibody responses, investigators at Thomas Jefferson University found.

Asthma patients benefited from flu vaccines, according to a study that examined 6 influenza virus seasons.

While results of a study on crowdsourced materials promoting hepatitis testing were complicated by intervention sharing, 20% of MSM reported first time testing.

A new study examines the association between vaccine-preventable disease incidence and state vaccine exemption legislation.

After analyzing electronic medical records from 161 patients across 90 VHA sites, investigators determined that patients initiated 94% of conversations about PrEP.

The vaccine candidate, TAK-003, is based on a live-attenuated dengue serotype 2 virus, which provides the genetic “backbone” for all 4 serotypes.

Modified vaccinia Ankara vaccination showed efficacy protecting against smallpox in a phase 3 clinical trial, with fewer adverse events reported compared to the ACAM2000 vaccine group.

Timothy Ray Brown, formerly known as the “Berlin Patient” explains why it is important for providers to form relationships with patients and avoid stigma and judgment.

A prediction model using prior health care exposure information could discern patients likely to harbor carbapenem-resistant Enterobacteriaceae at time of hospital admission.

Several key populations with heightened risk for HIV face criminalization in Botswana. The Botswana Family Welfare Association targeted efforts to improve care for these key populations.

An educational research study reveals positive attitudes and a willingness to provide care among pre-licensure Bachelor of Science nursing students.

A new study examined young adults with perinatally acquired HIV living in South Florida in order to shed light on their lived experiences.

“My story is important only because it proves that HIV can be cured. And if something has happened, once in medical science, it can happen again,” Brown told Contagion®.

Neither infectious disease specialists nor primary care providers appear to consider PrEP care to fall within their practice, and similar debates have taken place between nurses and physicians.

Since 2014 NYC Health + Hospitals has worked to maintain preparedness against diseases like Ebola.

Fluzone High-Dose Quadrivalent is given to people 65 years of age and older to help prevent influenza disease caused by influenza A and B strains contained in the vaccine.

While most influenza vaccines target the binding protein hemagglutinin, a new study shows cross-strain results for treatment and prevention focused on the glycoprotein neuraminidase.

An analysis of vaccination data among children born in 2015 and 2016 found high and stable coverage, but highlighted sociodemographic disparities in coverage.

A study of female adolescents at a health clinic in New York City has found the presence of HPV in the oral cavity is not uncommon, but the results also offer support for vaccination.

According to the WHO’s latest Global TB Report, more than 7 million individuals received treatment for the disease in 2018, but funding gaps could stall progress toward ending TB by 2030.

H3N2, a particularly virulent strain of influenza, blew through Australia. Is it coming to the United States this fall and winter?

A new study points to an increased risk for infections in patients with PTSD.

A group provides an overview of ongoing research and current approaches being evaluated for the prevention of tick-borne disease.

Kindergarten vaccination coverage is near the recommended 95%, but nonexempt holdouts, which could be addressed, can still lead to outbreaks.

Scientists from the National Institutes of Health are hopeful that diluting a dose of the VSV vaccine could be efficacious and stretch vaccine supplies even further.

Gregory Felzien, MD, AAHIVS, discusses prevention beyond PrEP and creating a safe environment for patients with HIV.

Using a unique approach of targeting the stalk of the hemagglutinin, investigators are taking steps toward developing a universal influenza vaccine candidate.

Gregory Felzien, MD, AAHIVS, discusses barriers to HIV care, particularly in neglected rural areas.